Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (1,424) Arrow Down
Filter Results: (1,424) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (1,424)
    • News  (360)
    • Research  (762)
    • Events  (1)
    • Multimedia  (59)
  • Faculty Publications  (507)

Show Results For

  • All HBS Web  (1,424)
    • News  (360)
    • Research  (762)
    • Events  (1)
    • Multimedia  (59)
  • Faculty Publications  (507)
← Page 4 of 1,424 Results →
  • 2022
  • Working Paper

Addressing Vaccine Hesitancy: Experimental Evidence from Nine Countries during the COVID-19 Pandemic

By: Vincenzo Galasso, Vincent Pons, Paola Profeta, Michael Becher, Sylvain Brouard and Martial Foucault
Millions of people refuse COVID-19 vaccination. Using original data from two surveys in nine OECD countries, we analyze the determinants of anti-vax intentions in December 2020 and show that half of the anti-vax individuals were vaccinated by summer 2021. Vaccinations... View Details
Keywords: COVID-19; Vaccination; Vaccine Hesitancy; Information Campaigns; Health Pandemics; Behavior; Information
Citation
Read Now
Related
Galasso, Vincenzo, Vincent Pons, Paola Profeta, Michael Becher, Sylvain Brouard, and Martial Foucault. "Addressing Vaccine Hesitancy: Experimental Evidence from Nine Countries during the COVID-19 Pandemic." NBER Working Paper Series, No. 29741, February 2022.
  • 2021
  • Article

Don't Get It or Don't Spread It: Comparing Self-interested versus Prosocial Motivations for COVID-19 Prevention Behaviors

By: Jillian J. Jordan, Erez Yoeli and David Rand
COVID-19 prevention behaviors may be seen as self-interested or prosocial. Using American samples from MTurk and Prolific (total n = 6,850), we investigated which framing is more effective—and motivation is stronger—for fostering prevention behavior intentions. We... View Details
Keywords: COVID-19; Prevention; Prosocial Motivation; Health Pandemics; Behavior; Motivation and Incentives
Citation
Read Now
Related
Jordan, Jillian J., Erez Yoeli, and David Rand. "Don't Get It or Don't Spread It: Comparing Self-interested versus Prosocial Motivations for COVID-19 Prevention Behaviors." Art. 20222. Scientific Reports 11 (2021).
  • 02 Jun 2020
  • Working Paper Summaries

HBS COVID-19 Global Policy Tracker

Keywords: by Alberto Cavallo and Tannya Cai; Health
  • November 2020
  • Article

Barriers to Hospital Electronic Public Health Reporting and Implications for the COVID-19 Pandemic

By: A Jay Holmgren, Nate Apathy and Julia Adler-Milstein
We sought to identify barriers to hospital reporting of electronic surveillance data to local, state, and federal public health agencies and the impact on areas projected to be overwhelmed by the COVID-19 pandemic. Using 2018 American Hospital Association data, we... View Details
Keywords: Electronic Health Records; Public Health; Syndromic Surveillance; Pandemic; COVID-19; Health Pandemics
Citation
Find at Harvard
Read Now
Related
Holmgren, A Jay, Nate Apathy, and Julia Adler-Milstein. "Barriers to Hospital Electronic Public Health Reporting and Implications for the COVID-19 Pandemic." Journal of the American Medical Informatics Association 27, no. 11 (November 2020).
  • September 2023 (Revised January 2024)
  • Case

AB InBev: Brewing Up Forecasts during COVID-19

By: Mark Egan, C. Fritz Foley, Esel Cekin and Emilie Billaud
In July 2021, the CEO of AB InBev's European operations and his team strategized to position the company for success post-pandemic. As the world's largest beer company, boasting over 500 brands, revenue of $46 billion, and a workforce of 160,000 in 2020, AB InBev... View Details
Keywords: Beer; Forecasting; COVID-19; Decision; Forecasting and Prediction; Analytics and Data Science; Crisis Management; Decisions; Financing and Loans; Investment Return; Resource Allocation; Distribution; Production; Business Processes; Strategic Planning; Health Pandemics; Digital Transformation; Markets; Food and Beverage Industry; Belgium; Europe; Latin America; North and Central America
Citation
Educators
Purchase
Related
Egan, Mark, C. Fritz Foley, Esel Cekin, and Emilie Billaud. "AB InBev: Brewing Up Forecasts during COVID-19." Harvard Business School Case 224-020, September 2023. (Revised January 2024.)
  • 15 Dec 2020
  • Research & Ideas

The Unspoken Messages of COVID-19 Restrictions

Soaring COVID-19 cases are forcing government officials to confront a critical question: Should they lock down the economy further? Whether to curb activities like indoor dining might seem like a simple choice, but the decision to ease... View Details
Keywords: by Danielle Kost; Food & Beverage
  • November 2020
  • Case

Wilderness Safaris: Responses to the COVID-19 Crisis

By: James E. Austin, Megan Epler Wood and Herman B. "Dutch" Leonard
This case is an epilogue to “Wilderness Safaris: Impact Investing and Ecotourism Conservation in Africa” (2-321-020), which ends with the emergence of the pandemic in March 2020. The final discussion area for that case can be “What should Wilderness Safari CEO Keith... View Details
Keywords: Communities; COVID-19; Ecotourism; Travel; Travel Industry; Conservation Planning; Reopening; Investor Relations; Project Strategy; Governance; Decision Making; Cash; Health Pandemics; Business and Shareholder Relations; Tourism Industry; Africa
Citation
Educators
Purchase
Related
Austin, James E., Megan Epler Wood, and Herman B. "Dutch" Leonard. "Wilderness Safaris: Responses to the COVID-19 Crisis." Harvard Business School Case 321-077, November 2020.
  • 2020
  • Working Paper

Venture Capitalists and COVID-19

By: Paul A. Gompers, Will Gornall, Steven N. Kaplan and Ilya A. Strebulaev
We survey over 1,000 institutional and corporate venture capitalists (VCs) at more than 900 different firms to learn how their decisions and investments have been affected by the COVID-19 pandemic. We compare their survey answers to those provided by a large sample of... View Details
Keywords: Venture Capital; Health Pandemics; Investment; Decision Making; Surveys
Citation
Read Now
Related
Gompers, Paul A., Will Gornall, Steven N. Kaplan, and Ilya A. Strebulaev. "Venture Capitalists and COVID-19." NBER Working Paper Series, No. 27824, September 2020.
  • 28 Jun 2021
  • News

Three Tactics to Overcome COVID-19 Vaccine Hesitancy

  • 2022
  • Working Paper

Causal Inference During A Pandemic: Evidence on the Effectiveness of Nebulized Ibuprofen as an Unproven Treatment for COVID-19 in Argentina

By: Sebastian Calonico, Rafael Di Tella and Juan Cruz Lopez Del Valle
Many medical decisions during the pandemic were made without the support of causal evidence obtained in clinical trials. We study the case of nebulized ibuprofen (NaIHS), a drug that was extensively used on COVID-19 patients in Argentina amidst wild claims about its... View Details
Keywords: COVID-19; Drug Treatment; Health Pandemics; Health Care and Treatment; Decision Making; Outcome or Result; Argentina
Citation
Find at Harvard
Read Now
Related
Calonico, Sebastian, Rafael Di Tella, and Juan Cruz Lopez Del Valle. "Causal Inference During A Pandemic: Evidence on the Effectiveness of Nebulized Ibuprofen as an Unproven Treatment for COVID-19 in Argentina." NBER Working Paper Series, No. 30084, May 2022.
  • June 2021 (Revised October 2021)
  • Case

Nissan's Response to the COVID-19 Pandemic

By: Ananth Raman, William Schmidt and Ann Winslow
In January 2020, Ashwani Gupta took over as COO at Nissan Motor Corporation, and several weeks later, the COVID-19 pandemic began. Nissan’s Business Continuity Plan (BCP) had been key to the resilience of Nissan’s supply chain. It had enabled Nissan to recover from... View Details
Keywords: Operations; Supply Chain Management; Health Pandemics; Auto Industry; Manufacturing Industry; Japan; India
Citation
Educators
Purchase
Related
Raman, Ananth, William Schmidt, and Ann Winslow. "Nissan's Response to the COVID-19 Pandemic." Harvard Business School Case 621-057, June 2021. (Revised October 2021.)
  • 15 May 2020
  • News

Five ESG Implications from COVID-19

  • 26 May 2020
  • Podcast

Covid-19 Dispatch: Hayden Brown

Hayden Brown has been Upwork’s CEO since January 2020, just before the coronavirus pandemic shifted much of the workforce to working from home. Upwork is a leading platform connecting freelance workers to businesses who need help. Hayden shares with what changes she... View Details
  • 11 May 2020
  • Podcast

Covid-19 Dispatch: Karen Mills

Return guest, Harvard Business School senior fellow Karen Mills, is uniquely qualified to assert that the Covid-19 pandemic poses a greater threat to US small businesses than the Great Recession of 2008-2009. She directed the Small Business Administration from 2009 to... View Details
  • 04 May 2020
  • Podcast

Covid-19 Dispatch: Sham Kakade

Contact tracing—mapping the spread of a virus by identifying individuals in the chain of transmission—is an essential tool in the fight to limit the damage of Covid-19. Early experience in South Korea, China, Singapore, Germany, and elsewhere has shown what works.... View Details
  • 29 Apr 2020
  • Podcast

Covid-19 Dispatch: Nick Dalton

Unilever was several years into a company-wide plan to revamp its workforce when the coronavirus flared into a pandemic. The multinational entered the crisis braced for change. Executive vice president Nick Dalton discusses how that flexibility has helped Unilever... View Details
  • 15 Apr 2020
  • Podcast

Covid-19 Dispatch: Ardine Williams

The pandemic has magnified Amazon’s role as household supply line and pushed the company to quickly adjust how it does business. The retail giant has revised scores of operating processes in response to customer demand, workplace safety requirements, and public health... View Details
  • March 2022
  • Article

Assessing the Impact of the COVID-19 Pandemic on Clinician Ambulatory Electronic Health Record Use

By: A Jay Holmgren, Lance Downing, Mitchell Tang, Christopher Sharp, Christopher Longhurst and Robert S. Huckman
Objective: The COVID-19 pandemic changed clinician electronic health record (EHR) work in a multitude of ways. To evaluate how, we measure ambulatory clinician EHR use in the United States throughout the COVID-19 pandemic.

Materials and Methods: We use EHR... View Details
Keywords: Health Care; Electronic Health Records; Productivity; COVID-19 Pandemic; Health Care and Treatment; Health Pandemics; Information Technology; Performance Productivity; United States
Citation
Find at Harvard
Read Now
Related
Holmgren, A Jay, Lance Downing, Mitchell Tang, Christopher Sharp, Christopher Longhurst, and Robert S. Huckman. "Assessing the Impact of the COVID-19 Pandemic on Clinician Ambulatory Electronic Health Record Use." Journal of the American Medical Informatics Association 29, no. 3 (March 2022): 453–460.
  • 10 Apr 2020
  • News

MBAs Fight COVID-19

  • 27 Jul 2020
  • Blog Post

HBS Summer Fellows Respond to COVID-19

The HBS Summer Fellowship Program provides an opportunity for students to develop skills and knowledge while having significant responsibility and high impact. This summer, HBS is supporting a record 162 Social Enterprise Summer Fellows, with many organizations and... View Details
  • ←
  • 4
  • 5
  • …
  • 71
  • 72
  • →
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College.